IMC Chicago
AXSM icon

IMC Chicago’s Axsome Therapeutics AXSM Stock Holding History

IMC Chicago’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.69M Buy
20,000
+5,000
+33% +$1.09M ﹤0.01% 2525
2026
Q2 		$3.67M Buy
15,000
+3,600
+32% +$781K ﹤0.01% 2427
2026
Q1 		$1.93M Sell
11,400
-12,200
-52% -$2.11M ﹤0.01% 2614
2025
Q4 		$4.31M Buy
23,600
+10,500
+80% +$1.47M ﹤0.01% 1847
2025
Q3 		$1.59M Buy
+13,100
New +$1.48M ﹤0.01% 2398

Other funds holding AXSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

IMC Chicago's AXSM Position: Q3 2026 in Review

IMC Chicago increased its Axsome Therapeutics (AXSM) stake by 58% in Q3 2026, buying an estimated $1.29M and bringing the position to 16,112 shares worth $2.97M. The position accounts for ﹤0.01% of the portfolio, ranked #2757.

IMC Chicago first reported a position in AXSM in Q1 2026 and has held it in 3 quarters since. 235 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • IMC Chicago held 16,112 shares of Axsome Therapeutics worth $2.97M as of Q3 2026.
  • IMC Chicago bought 5,925 Axsome Therapeutics shares in Q3 2026, an estimated $1.29M.
  • Axsome Therapeutics made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #2757 holding.
  • IMC Chicago first reported a position in Axsome Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 235 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.